{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:43:34Z","timestamp":1773967414196,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014978","name":"Hunan University of Chinese Medicine","doi-asserted-by":"publisher","award":["2024CX132"],"award-info":[{"award-number":["2024CX132"]}],"id":[{"id":"10.13039\/501100014978","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020784","name":"Gannan Medical University","doi-asserted-by":"publisher","award":["XN202011"],"award-info":[{"award-number":["XN202011"]}],"id":[{"id":"10.13039\/501100020784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017712","name":"Ganzhou City Bureau of Science and Technology","doi-asserted-by":"publisher","award":["202101094460"],"award-info":[{"award-number":["202101094460"]}],"id":[{"id":"10.13039\/100017712","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023JJ30362"],"award-info":[{"award-number":["2023JJ30362"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ40099"],"award-info":[{"award-number":["2025JJ40099"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009102","name":"Education Department of Jiangxi Province","doi-asserted-by":"publisher","award":["GJJ190802"],"award-info":[{"award-number":["GJJ190802"]}],"id":[{"id":"10.13039\/501100009102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81904173"],"award-info":[{"award-number":["81904173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003824","name":"Hunan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Clinical Practice"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ctcp.2025.102042","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T23:36:47Z","timestamp":1767224207000},"page":"102042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Chinese patent medicine in the treatment of Parkinson's disease: A systematic review and network meta-analysis"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9085-0173","authenticated-orcid":false,"given":"Xiongying","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qilai","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ctcp.2025.102042_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria","volume":"23","author":"H\u00f6glinger","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ctcp.2025.102042_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and pathogenesis of Parkinson's syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu. Rev. Pathol."},{"issue":"25","key":"10.1016\/j.ctcp.2025.102042_bib3","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.2174\/1381612825666190716113444","article-title":"Adenosine A2A receptor as a potential drug target - current status and future perspectives","volume":"25","author":"Al-Attraqchi","year":"2019","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.ctcp.2025.102042_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global regional national burden of neurological disorders, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"GBD 2016 neurology collaborators","year":"2019","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.ctcp.2025.102042_bib5","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global regional national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"17","author":"GBD 2016 Parkinson's disease collaborators","year":"2018","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.ctcp.2025.102042_bib6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2401857","article-title":"Parkinson's disease","volume":"391","author":"Tanner","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ctcp.2025.102042_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jsmc.2025.06.007","article-title":"Non-motor subtypes of Parkinson's disease and sleep dysfunction","volume":"20","author":"Leta","year":"2025","journal-title":"Sleep Med. Clin."},{"issue":"1","key":"10.1016\/j.ctcp.2025.102042_bib8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41531-024-00843-7","article-title":"MRgFUS subthalamotomy in Parkinson's disease: an approach aimed at minimizing lesion volume","volume":"10","author":"Campins-Romeu","year":"2024","journal-title":"npj Parkinson's Dis."},{"issue":"1","key":"10.1016\/j.ctcp.2025.102042_bib9","first-page":"424","article-title":"Interactions between gut microbiota and parkinson's disease: the role of tryptophan metabolism, cell commun","volume":"23","author":"Fan","year":"2025","journal-title":"Signals"},{"issue":"8","key":"10.1016\/j.ctcp.2025.102042_bib10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson's disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.ctcp.2025.102042_bib11","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s10072-023-07233-6","article-title":"Objective assessment of the effects of opicapone in Parkinson's disease through kinematic analysis","volume":"45","author":"Bologna","year":"2024","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.ctcp.2025.102042_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JPD-225060","article-title":"Pharmacological treatment of tremor in Parkinson's disease revisited","volume":"13","author":"Pirker","year":"2023","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ctcp.2025.102042_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.139875","article-title":"Identification of novel phenolic inhibitors from traditional Chinese medicine against toxic \u03b1-synuclein aggregation via regulating phase separation","volume":"297","author":"Yu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ctcp.2025.102042_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117628","article-title":"Piperine promotes PI3K\/AKT\/mTOR-mediated gut-brain autophagy to degrade \u03b1-Synuclein in Parkinson's disease rats","volume":"322","author":"Yu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ctcp.2025.102042_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155494","article-title":"Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation","volume":"127","author":"He","year":"2024","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.ctcp.2025.102042_bib16","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1002\/ptr.8322","article-title":"Progress of exosomal microRNAs and traditional Chinese medicine monomers in neurodegenerative diseases","volume":"38","author":"Liang","year":"2024","journal-title":"Phytother Res."},{"issue":"5","key":"10.1016\/j.ctcp.2025.102042_bib17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.joim.2024.07.002","article-title":"Efficacy and safety of Tianqi Pingchan granule, a compound Chinese herbal medicine, for levodopa-induced dyskinesia in Parkinson's disease: a randomized double-blind placebo-controlled trial","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Integr. Med."},{"issue":"39","key":"10.1016\/j.ctcp.2025.102042_bib18","article-title":"Ginsenoside Rg3 restores mitochondrial cardiolipin homeostasis via GRB2 to prevent Parkinson's disease","volume":"11","author":"Qi","year":"2024","journal-title":"Adv. Sci. (Weinh)."},{"issue":"4","key":"10.1016\/j.ctcp.2025.102042_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/1570161112666141014150232","article-title":"Effects and perspectives of Chinese patent medicines for tonifying Qi and promoting blood circulation on patients with cerebral infarction","volume":"13","author":"Zhou","year":"2015","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.ctcp.2025.102042_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464042","article-title":"Three-dimensional characteristic chromatogram by online comprehensive two-dimensional liquid chromatography: application to the identification and differentiation of ginseng from herbal medicines to various Chinese patent medicines","volume":"1700","author":"Xu","year":"2023","journal-title":"J. Chromatogr., A"},{"issue":"15","key":"10.1016\/j.ctcp.2025.102042_bib21","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): Scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.ctcp.2025.102042_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.ctcp.2025.102042_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jnnp.73.6.629","article-title":"The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease","volume":"73","author":"Chaudhuri","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5\u20136","key":"10.1016\/j.ctcp.2025.102042_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000523982","article-title":"Plasma cystatin C correlates with plasma NfL levels and predicts disease progression in Parkinson's disease","volume":"21","author":"Imarisio","year":"2021","journal-title":"Neurodegener. Dis."},{"issue":"3","key":"10.1016\/j.ctcp.2025.102042_bib25","article-title":"The severity assessment of Parkinson's disease based on plasma inflammatory factors and third ventricle width by transcranial sonography, CNS Neurosci","volume":"30","author":"Lu","year":"2024","journal-title":"Therapy"},{"issue":"2","key":"10.1016\/j.ctcp.2025.102042_bib26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/psyg.12483","article-title":"Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson's disease","volume":"20","author":"Li","year":"2020","journal-title":"Psychogeriatrics"},{"issue":"1","key":"10.1016\/j.ctcp.2025.102042_bib27","article-title":"The involvement of the synaptic vesicle cycle in homocysteine induced neurotoxicity in vitro and in vivo","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ctcp.2025.102042_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13745","article-title":"N-Homocysteinylation of \u03b1-synuclein promotes its aggregation and neurotoxicity","volume":"22","author":"Zhou","year":"2023","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.ctcp.2025.102042_bib29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.27292","article-title":"\u03b1-Synuclein-Related mitochondria-Nrf2 dysfunction in Parkinson's disease olfactory mucosa","volume":"98","author":"Maftei","year":"2025","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.ctcp.2025.102042_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s10735-024-10307-0","article-title":"Neuroprotective effect of Bacillus subtilis in haloperidol induced rat model, targeting the microbiota-gut-brain axis","volume":"56","author":"Rout","year":"2024","journal-title":"J. Mol. Histol."},{"issue":"2","key":"10.1016\/j.ctcp.2025.102042_bib31","first-page":"302","article-title":"Analysis of 116 cases of Parkinson's disease treated with Bushen Huoxue granules, Guangming J","volume":"29","author":"Xu","year":"2014","journal-title":"Chin. Med."},{"issue":"1","key":"10.1016\/j.ctcp.2025.102042_bib32","first-page":"16","article-title":"Clinical study of Bushen Huoxue granule in treatment of Parkinson's disease","volume":"20","author":"Zhang","year":"2013","journal-title":"Chin. J. Inf. Tradit. Chin. Med."},{"key":"10.1016\/j.ctcp.2025.102042_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ctim.2016.09.008","article-title":"Multi-dimensional analysis on Parkinson's disease questionnaire-39 in Parkinson's patients treated with Bushen Huoxue granule: a multicenter, randomized, double-blinded and placebo controlled trial","volume":"29","author":"Li","year":"2016","journal-title":"Compl. Ther. Med."},{"issue":"4","key":"10.1016\/j.ctcp.2025.102042_bib34","first-page":"2358","article-title":"Clinical study on the treatment of Parkinson's disease with liver-kidney Yin deficiency syndrome with Xifeng Dingchan pills","volume":"37","author":"Huang","year":"2022","journal-title":"China J. Tradit. Chin. Med. Pharm."},{"key":"10.1016\/j.ctcp.2025.102042_bib35","series-title":"The clinical study on the clinical efficacy and safety of XifengDingchan pill in treatment with Parkinson's disease in middle-stage deficiency of liver Yin and kidney Yin[Master's thesis]","author":"Lou","year":"2018"},{"issue":"4","key":"10.1016\/j.ctcp.2025.102042_bib36","first-page":"587","article-title":"Clinical research of Xifeng Dingchan pill treatment of Yin deficiency syndrome of liver and kidney of Parkinson's disease","volume":"28","author":"Ma","year":"2013","journal-title":"Acta Chin. Med."},{"issue":"2","key":"10.1016\/j.ctcp.2025.102042_bib37","first-page":"47","article-title":"Xifeng Dingchan pills in the treatment of 64 cases of Parkinson's disease","volume":"23","author":"Zhang","year":"2015","journal-title":"China\u2019s Naturopathy"},{"issue":"2","key":"10.1016\/j.ctcp.2025.102042_bib38","first-page":"125","article-title":"Effect of Xifeng Dingchan pill on the syndrome of liver and kidney deficiency of Parkinson's disease: a report of 30 cases","volume":"51","author":"Bai","year":"2010","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.ctcp.2025.102042_bib39","first-page":"39","article-title":"Clinical research of Xifeng Dingchan pill treatment of Yin deficiency syndrome of liver and kidney of Parkinson's disease, Tradit","author":"Ma","year":"2008","journal-title":"Chin. Med. Res. (03)"},{"issue":"1","key":"10.1016\/j.ctcp.2025.102042_bib40","first-page":"35","article-title":"Study on the effect of Xifeng Dingchan pill on the dosage of madopar in patients with Parkinson's disease","author":"Cheng","year":"2007","journal-title":"Shanxi J. Tradit. Chin. Med"},{"issue":"3","key":"10.1016\/j.ctcp.2025.102042_bib41","first-page":"19","article-title":"Adding Xifeng Dingchan pills in the treatment of Parkinson's diseases with liver and kidney Yin deficiency","volume":"44","author":"Li","year":"2021","journal-title":"Guangxi J. Tradit. Chin. Med."},{"issue":"5","key":"10.1016\/j.ctcp.2025.102042_bib42","first-page":"46","article-title":"The efficacy and safety of Shenzhi capsules combined with compound carbidopa tablets in treatment of patients with Parkinson's disease and its effect on serum CysC, Hcy and brain neurotransmitters","volume":"41","author":"Ding","year":"2018","journal-title":"J. Yunnan Univ. Chin. Med."},{"key":"10.1016\/j.ctcp.2025.102042_bib43","first-page":"32","article-title":"Effect of Shenzhi capsules on oxidative stress and neurological function in Parkinson's disease","author":"Chen","year":"2023","journal-title":"Diagnost. Brain Med."},{"issue":"5","key":"10.1016\/j.ctcp.2025.102042_bib44","first-page":"67","article-title":"Clinical effect of Qishen Huanwu capsules on Parkinson's disease with Qi and blood deficiency","volume":"20","author":"Wang","year":"2023","journal-title":"China Med. Her."},{"issue":"1","key":"10.1016\/j.ctcp.2025.102042_bib45","first-page":"29","article-title":"Effect of Qishen Huanwu capsule on UPDRS scores and balance ability of Parkinson's disease patients with Qi and blood deficiency","volume":"21","author":"Jing","year":"2022","journal-title":"Chin. J. Mult. Organ. Dis. Elderly."},{"issue":"12","key":"10.1016\/j.ctcp.2025.102042_bib46","first-page":"105","article-title":"Clinical observation of QishenHuanwu capsules in the adjuvant treatment of Parkinson's disease with Qi-Blood deficiency pattern","volume":"31","author":"Qiu","year":"2022","journal-title":"China Pharm."},{"issue":"21","key":"10.1016\/j.ctcp.2025.102042_bib47","first-page":"2479","article-title":"Clinical effect of Qishen Huanwu capsules combined with levodopa and benserazide hydrochloride for treating Parkinson's disease of blood stasis due to Qi deficiency symdrome","volume":"44","author":"Yuan","year":"2022","journal-title":"Guangxi Med. J."},{"issue":"6","key":"10.1016\/j.ctcp.2025.102042_bib48","first-page":"314","article-title":"Observation on curative effect of Tianma Gouteng granules combined with madopar in treatment of 68 cases of Parkinson's disease","volume":"26","author":"Liu","year":"2012","journal-title":"Med. J. Liaoning"},{"issue":"9","key":"10.1016\/j.ctcp.2025.102042_bib49","first-page":"25","article-title":"Clinical study on treatment of non-motor symptoms of Parkinson's disease by Zishen Pingchan granules","volume":"24","author":"Yuan","year":"2017","journal-title":"Chin. J. Inf. Tradit. Chin. Med."},{"issue":"7","key":"10.1016\/j.ctcp.2025.102042_bib50","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.4103\/1673-5374.235075","article-title":"Zishen Pingchan granules for the treatment of Parkinson's disease: a randomized, double-blind, placebo-controlled clinical trial","volume":"13","author":"Ye","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ctcp.2025.102042_bib51","series-title":"The clinical observation on the effect of Congrong Shujing granule on muscular tension in parkinson's disease[Master's thesis]","author":"Lin","year":"2022"},{"issue":"6","key":"10.1016\/j.ctcp.2025.102042_bib52","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11655-020-3080-0","article-title":"Clinical efficacy and transcriptomic analysis of Congrong Shujing granules in patients with Parkinson's disease and syndrome of Shen (kidney) essence deficiency","volume":"26","author":"Chen","year":"2020","journal-title":"Chin. J. Integr. Med."},{"issue":"2","key":"10.1016\/j.ctcp.2025.102042_bib53","first-page":"63","article-title":"Clinical study of Tianma Gouteng granules combined with Madopar in the treatment of Parkinson's disease","volume":"16","author":"Wang","year":"2019","journal-title":"China Med. Her."},{"issue":"1","key":"10.1016\/j.ctcp.2025.102042_bib54","first-page":"95","article-title":"Efficacy of Tianma Gouteng granules combined with levodopa in treatment of Parkinson's disease and the effect on serum inflammatory factors and SOD, MDA, Cys-C, Chin","volume":"16","author":"Gu","year":"2018","journal-title":"J. Integr. Med. Cardio-Cerebrovasc. Dis."},{"issue":"8","key":"10.1016\/j.ctcp.2025.102042_bib55","first-page":"1902","article-title":"Clinical study on Tianma Gouteng granules combined with selegiline in treatment of Parkinson's disease","volume":"33","author":"Zuo","year":"2018","journal-title":"Drugs Clin."},{"issue":"3","key":"10.1016\/j.ctcp.2025.102042_bib56","first-page":"403","article-title":"Clinical observation of Tianma Gouteng granules combined with levodopa in treatment of Parkinson's disease","volume":"32","author":"Zhao","year":"2017","journal-title":"Drugs. Clin."},{"issue":"12","key":"10.1016\/j.ctcp.2025.102042_bib57","first-page":"2313","article-title":"Effects of Tianma Gouteng Yin and Mdopa on serum inflammatory factor, sleep quality and activity of daily life in Parkinson's patients","volume":"31","author":"Yuan","year":"2019","journal-title":"Clin. J. Tradit. Chin. Med."},{"issue":"5","key":"10.1016\/j.ctcp.2025.102042_bib58","first-page":"102","article-title":"Efficacy of Tianma Gouteng granules plus pramipexole hydrochloride tablets in Parkinson's disease and their regulatory effect on inflammatory response","volume":"49","author":"Yan","year":"2021","journal-title":"J. Guangzhou Med. Univ."},{"key":"10.1016\/j.ctcp.2025.102042_bib59","article-title":"A randomized controlled trial of Chinese medicine on nonmotor symptoms in Parkinson's disease","volume":"2017","author":"Chua","year":"2017","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.ctcp.2025.102042_bib60","doi-asserted-by":"crossref","DOI":"10.1093\/ecam\/nep116","article-title":"Treatment of idiopathic Parkinson's disease with traditional Chinese herbal medicine: a randomized placebo-controlled pilot clinical study","volume":"2011","author":"Kum","year":"2011","journal-title":"Evid. Based Complement Alternat. Med."},{"issue":"26","key":"10.1016\/j.ctcp.2025.102042_bib61","first-page":"185","article-title":"Clinical analysis of wuling capsule on Parkinson's disease with depression","volume":"19","author":"Zu","year":"2019","journal-title":"World Latest Med. Inf."},{"issue":"19","key":"10.1016\/j.ctcp.2025.102042_bib62","first-page":"3289","article-title":"Clinical study on pramipexole combined with wuling capsule in the treatment of Parkinson's disease with depression","volume":"36","author":"Chen","year":"2023","journal-title":"J. Med. Theor. Pract."},{"issue":"8","key":"10.1016\/j.ctcp.2025.102042_bib63","first-page":"53","article-title":"Clinical study on Yangxue Qingnao pills for early Parkinson's disease, new","volume":"55","author":"Yu","year":"2023","journal-title":"Chin. Med."},{"issue":"12","key":"10.1016\/j.ctcp.2025.102042_bib64","first-page":"2963","article-title":"The efficacy of Tiandan Tongluo capsule in the treatment of non-motor symptoms of Parkinson's disease and its effect on oxidative stress and inflammatory response indicators","volume":"42","author":"Lin","year":"2019","journal-title":"J. Chin. Med. Mater."},{"issue":"1","key":"10.1016\/j.ctcp.2025.102042_bib65","first-page":"32","article-title":"Clinical study on Qishen Huanwu capsules combined with dopamine hydrazinein treatment of Parkinson's disease of Qi deficiency and blood stasis type and its effect on serum cystatin C and homocysteine","volume":"26","author":"Liu","year":"2024","journal-title":"J. Hubei Univ. Chin. Med."},{"key":"10.1016\/j.ctcp.2025.102042_bib66","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/342506","article-title":"Effect of Zishen Pingchan granule on neurobehavioral manifestations and the activity and gene expression of striatal dopamine d1 and d2 receptors of rats with levodopa-induced dyskinesias","volume":"2014","author":"Ye","year":"2014","journal-title":"Evid. Based Complement Alternat. Med."},{"key":"10.1016\/j.ctcp.2025.102042_bib67","article-title":"Mechanism of tonifying-kidney Chinese herbal medicine in the treatment of chronic heart failure","volume":"9","author":"Chen","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"10","key":"10.1016\/j.ctcp.2025.102042_bib68","first-page":"2534","article-title":"Repetitive transcranial magnetic stimulation therapy combined with Bushen Huoxue granule on Parkinson's disease patients' dysfunction,affective disorder and clinical symptoms improvement","volume":"36","author":"Zhou","year":"2018","journal-title":"Chin. Arch. Tradit. Chin. Med."},{"key":"10.1016\/j.ctcp.2025.102042_bib69","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.2147\/DDDT.S542423","article-title":"Traditional Chinese medicine in the comprehensive management of Tourette syndrome: insights from genetics and pathophysiology: a review","volume":"19","author":"Yu","year":"2025","journal-title":"Drug Des. Dev. Ther."},{"issue":"3","key":"10.1016\/j.ctcp.2025.102042_bib70","first-page":"239","article-title":"Tianma Gouteng Yin and its single herb in treatment of Parkinson's disease: a review","volume":"30","author":"Zhu","year":"2024","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"issue":"24","key":"10.1016\/j.ctcp.2025.102042_bib71","first-page":"4046","article-title":"Influences of Zishen Pingchan decoction and benserazide tablets on PSQI, TESS score and quality of life in the elderly Parkinson's disease patients with insomnia, Chin","volume":"17","author":"Zhang","year":"2019","journal-title":"J. Integr. Med. on Cardio - Cerebrovasc. Dis."},{"issue":"1","key":"10.1016\/j.ctcp.2025.102042_bib72","first-page":"104","article-title":"The effects of Qishen Huanwu capsule combined with butylphthalide on cognitiveImpairment and p38 MAPK pathway in patients with phlegm blood stasis syn-drome of early vascular dementia","volume":"18","author":"Wang","year":"2023","journal-title":"World J. Integr. Tradit. West. Med."},{"issue":"1","key":"10.1016\/j.ctcp.2025.102042_bib73","first-page":"73","article-title":"Effects of Xifeng Dingchan decoction combined with domperidone on cognitive function and neuro-transmitter levels in patients with Parkinson's disease","volume":"38","author":"Gao","year":"2024","journal-title":"Med. J. Liaoning"},{"issue":"15","key":"10.1016\/j.ctcp.2025.102042_bib74","first-page":"95","article-title":"Observation of efficacy of Tiandan Tongluo capsule in the treatment of patients with cerebral thrombosis in convalescent phase","volume":"17","author":"Wang","year":"2022","journal-title":"Chin. Pract. Med."}],"container-title":["Complementary Therapies in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744388125001070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744388125001070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:49:47Z","timestamp":1773960587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744388125001070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":74,"alternative-id":["S1744388125001070"],"URL":"https:\/\/doi.org\/10.1016\/j.ctcp.2025.102042","relation":{},"ISSN":["1744-3881"],"issn-type":[{"value":"1744-3881","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chinese patent medicine in the treatment of Parkinson's disease: A systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctcp.2025.102042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102042"}}